Not applicableStudy completedNCT04215367What this trial is testingDietary Intervention With High Phenolic EVOO in CLLWho this might be right forChronic Lymphocytic Leukemia (CLL) University of Peloponnese 21
Not applicableStudy completedNCT04774744What this trial is testingEffect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic LeukemiaWho this might be right forAcute Myeloid LeukemiaChronic Lymphocytic Leukemia M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)UnknownNCT00002481What this trial is testingCombination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma St. Luke's Medical Center
Not applicableLooking for participantsNCT06151730What this trial is testingEvaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT StudyWho this might be right forChronic Lymphocytic LeukemiaHematopoietic and Lymphoid System NeoplasmMantle Cell Lymphoma+2 more Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT00309881What this trial is testingCombination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)Who this might be right forChronic Lymphocytic Leukemia German CLL Study Group 75
Early research (Phase 1)Active Not RecruitingNCT03913949What this trial is testingEvaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic MalignanciesWho this might be right forChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Ascentage Pharma Group Inc. 74
Not applicableStudy completedNCT05095155What this trial is testingStudy of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh NationalityWho this might be right forB Cell LeukemiaLymphoma Asfendiyarov Kazakh National Medical University 400
Early research (Phase 1)Temporarily pausedNCT02117336What this trial is testingClinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forRelapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Piramal Enterprises Limited 36
Testing effectiveness (Phase 2)UnknownNCT05322733What this trial is testingOrelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLLWho this might be right forChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma The First Affiliated Hospital with Nanjing Medical University 25
Not applicableActive Not RecruitingNCT06205498What this trial is testingAcalabrutinib Real World Italian obSErvational Study -ARISEWho this might be right forChronic Lymphocytic Leukemia AstraZeneca 151
Testing effectiveness (Phase 2)Study completedNCT00241358What this trial is testingStudy Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological MalignanciesWho this might be right forLeukemia, Myeloid, AcuteLeukemia, Myelogenous, ChronicLeukemia, Lymphoblastic, Acute+5 more Washington University School of Medicine 92
Testing effectiveness (Phase 2)Study completedNCT01258998What this trial is testingStudy of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+33 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT01868893What this trial is testingAn Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Genentech, Inc. 20
Early research (Phase 1)Study completedNCT00054236What this trial is testingCombination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+3 more Case Comprehensive Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00410163What this trial is testingOfatumumab With Fludarabine and Cyclophosphamide in B-CLL PatientsWho this might be right forLeukaemia, Lymphocytic, Chronic GlaxoSmithKline 61
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Not applicableWithdrawnNCT02020109What this trial is testingEvaluation of Splenic Irradiation in Chronic Lymphatic LeukemiaWho this might be right forLeukemia, Chronic Lymphatic Maastricht Radiation Oncology
Testing effectiveness (Phase 2)Study completedNCT00759798What this trial is testingIdentifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic LeukemiaLeukemia M.D. Anderson Cancer Center 289
Early research (Phase 1)Looking for participantsNCT06980116What this trial is testingDose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell MalignanciesWho this might be right forRelapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Early research (Phase 1)UnknownNCT00004036What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more The Cleveland Clinic 30